Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05435339
Title A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.